In Veritas Medical Diagnostics, Inc.
IVME · OTC
7/31/2021 | 7/31/2007 | 7/31/2006 | 7/31/2005 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1,271 | $880 |
| % Growth | – | -100% | 44.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $5 |
| Gross Profit | $0 | $0 | $1,271 | $875 |
| % Margin | – | – | 100% | 99.5% |
| R&D Expenses | $0 | $711 | $1,307 | $1,160 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $108 | $2,006 | $1,059 | $1,953 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $108 | $2,718 | $2,230 | $3,141 |
| Operating Income | -$108 | $2,718 | $959 | $2,266 |
| % Margin | – | – | 75.4% | 257.5% |
| Other Income/Exp. Net | $0 | -$953 | -$890 | -$185 |
| Pre-Tax Income | -$108 | -$3,671 | -$1,849 | -$2,451 |
| Tax Expense | $0 | -$5,435 | $890 | $185 |
| Net Income | -$108 | -$3,671 | -$1,849 | -$2,451 |
| % Margin | – | – | -145.4% | -278.5% |
| EPS | -0.001 | -0.062 | -0.034 | -0.047 |
| % Growth | 97.9% | -84.8% | 27.9% | – |
| EPS Diluted | -0.002 | -0.062 | -0.034 | -0.047 |
| Weighted Avg Shares Out | 60,418 | 59,146 | 55,095 | 52,542 |
| Weighted Avg Shares Out Dil | 60,418 | 59,146 | 55,095 | 52,542 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $428 | $0 |
| Depreciation & Amortization | $0 | $8 | $16 | $28 |
| EBITDA | -$108 | -$2,709 | -$983 | -$2,238 |
| % Margin | – | – | -77.4% | -254.4% |